triple hormone receptor agonist retatrutide for obesity 2023年度回顧】 NEJM Notable Articles of 2023 Day 3: Triple–Hormone-Receptor — A Phase 2 Trial. N Engl J Med 2023; 389:514-526. 製圖：Sardinosis Today, we shared new data

Super easy to talk to, really knows her stuff, and makes the whole experience feel relaxed instead of awkward or overwhelming

One realized her sign of hunger was losing focus halfway through a meeting. Another noticed she became unreasonably irritable by late afternoonher bodys quiet way of asking for food

Accordingly, the aim of this review was twofold: to describe existing scientific evidence of the relationship between emphysema and LC, by examining the different mechanisms responsible

PMID: 2229314

GLP-1 medications like semaglutide and tirzepatide can help by reducing appetite and making a lower-calorie diet easier to maintain